Consistent Top-Line Growth and Scale
16th consecutive year of sales growth with net sales of $7.65 billion in fiscal 2025 (≈3% year-over-year; ≈5% when adjusted for 1 fewer selling week). Addressable market estimated at $44 billion and ~20% U.S. market share, with expanding presence in Canada.
Strong Cash Generation and Capital Returns
Operating cash flow of $650 million in fiscal 2025, representing ~70% conversion of adjusted EBITDA; free cash flow yield of 5.8% (about 3x specialty distribution peers). Returned $155 million to shareholders via share repurchases in FY25 plus $39 million subsequent, and over 20% of IPO shares repurchased since 2021.
Profitability and EPS Improvement
Adjusted EBITDA of $931 million (slightly ahead of prior year) and adjusted diluted EPS of $2.97, up 7% year-over-year, driven by lower interest expense and share repurchases.
Gross Margin Expansion and Private Label Momentum
Gross margin expanded by 30 basis points to 26.9% year-over-year, driven by higher private label penetration. Private label rose ~100 basis points to ~5% of sales, with a stated path to at least 10% over time.
Above‑Market Organic Growth and Product Initiatives
Delivered 3 points of organic above-market growth in FY25. Key initiatives (meters, treatment plant, fusible HDPE, geosynthetics) averaged ~14% annual growth over the last 5 years for meters/treatment-related initiatives and ~25% for large treatment delivery initiatives, with meter products up 12% in the quarter and mid-single digits for the year.
Disciplined M&A and Footprint Expansion
Acquisitions contributed ~2 points of sales growth in FY25 (Canada Waterworks, Pioneer Supply); opened 10 branches during/after the year and 6 greenfields in FY25 with plans to open 7–10 greenfields in FY26. Since 2017: >40 acquisitions, ~150 branches added and ~$1.8 billion of annual sales acquired.
Confident FY26 Outlook
Guidance for fiscal 2026: net sales $7.8–7.9 billion and adjusted EBITDA $950–$980 million; expects to grow adjusted EBITDA margins via gross margin initiatives and realized cost actions, and operating cash flow conversion targeted at 60%–70% of adjusted EBITDA.
Balance Sheet and Leverage in Target Range
Ended FY25 with net debt of ~$1.95 billion and net leverage of 2.1x (within target range of 1.5–3.0x) and liquidity of $1.45 billion (including $220 million cash and the remainder under ABL).